An underground economy for unapproved slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.
Investigational Drug Gaining Popularity Online
Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Followers are urged to contact these profiles privately for supplier links, while also receiving discount codes.
Active Commerce on Messaging Platforms
Separately, a flourishing trade exists on Telegram, where groups with numerous of participants share “before and after” photos, injection guides and assertions of next-day British shipping. Vendors market the substance there before directing buyers to other platforms for transactions.
Learning About Retatrutide
This medication is an experimental injection created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Experts Voice Concerns
Nevertheless, physicians and chemists have warned that the distribution of what is still an unapproved medication in the United Kingdom is a cause for concern and could lead to users administering products of unknown origin.
Some professionals stated the popularity for the experimental drug could be connected to the rising cost of approved slimming products such as Mounjaro.
Regulatory Position and Implementation
Selling retatrutide on social media or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.
Several influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate pharmaceutical, marketing, and customer regulations, potentially leading to penalties, legal action or imprisonment.
Platform Reaction and Material Elimination
According to TikTok, the platform has removed violative content and banned associated keywords and query recommendations. The organization said it was dedicated to keeping the service secure and investing in enhancing enforcement strategies.
Digital Trading Operations
Research also discovered groups with up to nine thousand participants selling retatrutide using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of users, populated with photos of weight loss, glowing testimonials and detailed instructions for mixing or injecting at residence.
Within minutes of entering one group, a seller posted WhatsApp details, where the majority of purchases occur. The vendor sent an instruction manual and promised delivery within two days. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about body mass, health issues or past usage.
Item Information and Costs
Within these groups, posts show dark colored packages with postal service labels, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors usually priced at £160 for 20mg. When asked how long a injector should last, vendors give conflicting answers ranging from a several days to “depends on your body”.
Platform Moderation and Safety Actions
A representative for the messaging service said it actively monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are administering materials they can’t verify. Although the science behind retatrutide is valid, these digital versions may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the surge in demand to current cost increases for approved slimming medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.
Her team has previously seen patients injured by personal administration from unconfirmed sources. “We understand the frustration, but buying from Telegram or communication platforms is taking chances with your well-being,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Statement
A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly investigational product not yet approved … may expose patients to potentially serious health risks”.
